SARS-CoV-2 Fulminant Myocarditis

Garot, Jérôme; Amour, Julien; Pezel, Théo; Dermoch, Firas; Messadaa, Kamel; Felten, Marie-Louise; Raymond, Valérie; Baubillier, E.; Sanguineti, Francesca; Garot, Philippe

doi:10.1016/j.jaccas.2020.05.060

Cited by 35 publications

(29 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Besides, the only indicator of myocardial inflammation may be diffuse edema when LGE is absent or minimal in CMRI [17]. In an 18-year-old patient with COVID-19, CMRI revealed increased LV wall thickness, increased LV volumes with marked diffuse hypokinesis, mild pericardial effusion and myocardial edema without perfusion defects [18]. By CMRI, regional wall motion abnormalities of the ventricles may also be determined [19].…”

Section: Discussionmentioning

confidence: 99%

Cardiac Magnetic Resonance Imaging in Patients with COVID-19

Erenler¹,

Komut²,

Baydın³

2020

RDI

View full text Add to dashboard Cite

In the beginning of December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was determined in Wuhan, Hubei, China. Besides its predominant respiratory system-related symptoms, cardiovascular involvement has also been described in adults with direct and indirect cardiac injury. Pre-existing cardiovascular disease and cardiac risk factors have been shown to increase the risk of cardiac complications of COVID-19 infection. However, it is also known that healthy and asymptomatic COVID-19 survivors suffer cardiac damage-related complications. Cardiac Magnetic Resonance Imaging (CMRI) is known to be the reference non-invasive standard to present cardiac function and tissue characterization. It is recommended as an effective and efficient diagnostic imaging choice to obtain critical information for clinical diagnosis and decision-making. In this article, we sought the usefulness of CMRI in cardiovascular complications related to COVID-19.

show abstract

Section: Discussionmentioning

confidence: 99%

Cardiac Magnetic Resonance Imaging in Patients with COVID-19

Erenler¹,

Komut²,

Baydın³

2020

RDI

View full text Add to dashboard Cite

show abstract

“…There are reports describing the importance of endomyocardial biopsy and cardiac MRI in this population. [ 6 , 12 ]…”

Section: Heart Failure Manifestation In Covid-19mentioning

confidence: 99%

“…Cardiac MRI has shown hypokinesis and diffuse myocardial oedema without evidence of late gadolinium enhancement. [ 12 ] Myocardial involvement and evidence of thrombosis have been recorded at autopsies but, because carrying these out poses risks to staff, hospital policies have restricted studies. There is a fine balance between scientific and clinical requirements and the occupational risk from exposure to SARS-CoV-2.…”

Section: Heart Failure Manifestation In Covid-19mentioning

confidence: 99%

See 1 more Smart Citation

Coronavirus Disease 2019 and Heart Failure: A Multiparametric Approach

et al. 2020

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) is a debilitating viral infection and, to date, 628,903 people have died from it, numbers that cannot yet be compared to the 50 million who died in the 1918 flu pandemic. As COVID-19 became better understood, cardiovascular manifestations associated with it were identified. This led to a complete healthcare restructuring with virtual clinics and changes to the triaging of critically ill patients. There are a lot of questions over how COVID-19 affects patients with heart failure (HF) as this condition is a leading cause of cardiovascular death. This review describes the cardiovascular implications of COVID-19 and new practices surrounding the use of telehealth to follow up and triage patients with HF. Current practices supported by medical societies, the role of angiotensin-converting enzyme inhibitors and, finally, a brief note regarding the management of advanced HF patients will also be discussed.

show abstract

“…Le SARS-Cov 2 a beaucoup plus rarement été responsable de véritables épisodes d’insuffisance cardiaque aiguë. Le tableau clinique peut alors être celui d’une myocardite fulminante avec état de choc, dysfonction ventriculaire gauche et élévation de troponine [28] , [29] , [30] , [31] , [32] , [33] . Des troubles du rythme ventriculaire ou des troubles conductifs de haut degré sont également possibles.…”

Section: Ecmo En Dehors Du Sdraunclassified

COVID-19 et assistance circulatoire

Hékimian

Frère

Collet

2020

Annales de Cardiologie et d'Angéiologie

View full text Add to dashboard Cite

La principale indication d’assistance chez les patients COVID-19 est le SDRA sévère en échec de traitement conventionnel. Les résultats de l’ECMO veino-veineuse sont comparables dans le COVID-19 à ceux obtenus dans les SDRA d’autres origines. La gestion de l’ECMO durant la pandémie COVID-19 a des spécificités liées à la maladie (comme par exemple la gestion de l’anticoagulation) et à l’allocation des ressources. Plus rarement, la COVID-19 peut se compliquer de défaillance hémodynamique dans le cadre d’une myocardite fulminante ou d’une embolie pulmonaire massive et nécessiter alors la mise en place d’une ECMO veino-artérielle. Bien que les cas rapportés soient peu nombreux, l’assistance circulatoire peut permettre une évolution favorable dans ces 2 indications.

show abstract

SARS-CoV-2 Fulminant Myocarditis

Cited by 35 publications

References 8 publications

Cardiac Magnetic Resonance Imaging in Patients with COVID-19

Cardiac Magnetic Resonance Imaging in Patients with COVID-19

Coronavirus Disease 2019 and Heart Failure: A Multiparametric Approach

COVID-19 et assistance circulatoire

Contact Info

Product

Resources

About